相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Zoledronate-activated V gamma 9 gamma delta T cell-based immunotherapy is feasible and restores the impairment of gamma delta T cells in patients with solid tumors
Atsutaka Noguchi et al.
CYTOTHERAPY (2011)
Adoptive Immunotherapy for Advanced Non-small Cell Lung Cancer Using Zoledronate-expanded γδ T Cells: A Phase I Clinical Study
Miki Sakamoto et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Human γδ T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement
Amudhan Maniar et al.
BLOOD (2010)
The MHC class Ib protein ULBP1 is a nonredundant determinant of leukemia/lymphoma susceptibility to γδ T-cell cytotoxicity
Telma Lanca et al.
BLOOD (2010)
Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vγ9Vδ2 T lymphocyte agonist in patients with solid tumors
Jaafar Bennouna et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Adoptive immunotherapy of cancer using ex vivo expanded human γδ T cells: A new approach
Pouneh Dokouhaki et al.
CANCER LETTERS (2010)
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-ASSOCIATED MALIGNANCIES
Heather M. Long et al.
DRUG NEWS & PERSPECTIVES (2010)
γδ T cell effector functions: a blend of innate programming and acquired plasticity
Marc Bonneville et al.
NATURE REVIEWS IMMUNOLOGY (2010)
A selective small-molecule nuclear factor-κB inhibitor from a high-throughput cell-based assay for activator protein-1 hits
Moon-Il Kang et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Cross-presenting human γδ T cells induce robust CD8+ αβ T cell responses
Marlene Brandes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma
Ryo Yamamoto et al.
BLOOD (2008)
Four novel ULBP splice variants are ligands for human NKG2D
Wei Cao et al.
INTERNATIONAL IMMUNOLOGY (2008)
CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer
Yoshiki Mizukami et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
TARC and IL-5 expression correlates with tissue eosinophilia in peripheral T-cell lymphomas
Caroline Thielen et al.
LEUKEMIA RESEARCH (2008)
Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes
Yue Ma et al.
BLOOD (2008)
Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study
Hirohito Kobayashi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Expansion of Vδ1 T lymphocytes producing IL-4 in low-grade non-Hodgkin lymphomas expressing UL-16-binding proteins
Silvia Catellani et al.
BLOOD (2007)
Perspectives of gamma delta T cells in tumor immunology
Dieter Kabelitz et al.
CANCER RESEARCH (2007)
Expression of macrophage-derived chemokine (MDC)/CCL22 in human lung cancer
Toru Nakanishi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Involvement of CD166 in the activation of human γδT cells by tumor cells sensitized with nonpeptide antigens
Yu Kato et al.
JOURNAL OF IMMUNOLOGY (2006)
Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma
ZZ Yang et al.
BLOOD (2006)
Vδ1 T cell receptor binds specifically to MHC I chain related A:: Molecular and biochemical evidences
JP Zhao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Tumor recognition following V gamma 9V delta 2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I
E Scotet et al.
IMMUNITY (2005)
FcγRIII discriminates between 2 subsets of Vγ9Vδ2 effector cells with different responses and activation pathways
DF Angelini et al.
BLOOD (2004)
Vδ1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid
A Poggi et al.
CANCER RESEARCH (2004)
The immunobiology of cancer immunosurveillance and immunoediting
GP Dunn et al.
IMMUNITY (2004)
Characterization of tumor reactivity of human Vγ9Vδ2 yδ T cells in vitro and in SCID mice in vivo
D Kabelitz et al.
JOURNAL OF IMMUNOLOGY (2004)
Effect of human natural killer and gamma delta T cells on the growth of human autologous melanoma xenografts in SCID mice
F Lozupone et al.
CANCER RESEARCH (2004)
Differentiation of effector/memory Vδ2 T cells and migratory routes in lymph nodes or inflammatory sites
F Dieli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Immobilized MICA could expand human Vδ1 γδ T cells in vitro that displayed major histocompatibility complex class I chain-related A-dependent cytotoxicity to human epithelial carcinomas
J Qi et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2003)
Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells
HJ Gober et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
HD Dong et al.
NATURE MEDICINE (2002)
The roles of IFNγ in protection against tumor development and cancer immunoediting
H Ikeda et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues
E Maggio et al.
ANNALS OF ONCOLOGY (2002)
Targeting of tumor cells for human γδ T cells by nonpeptide antigens
Y Kato et al.
JOURNAL OF IMMUNOLOGY (2001)
TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma
SC Peh et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2001)
分享论文
